Management of Node-Positive and Oligometastatic Prostate Cancer

被引:8
|
作者
Broughman, James R. [1 ,2 ]
Chen, Ronald C. [1 ,2 ,3 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Radiat Oncol, CB 7512, Chapel Hill, NC 27599 USA
[2] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA
[3] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
关键词
STEREOTACTIC BODY RADIOTHERAPY; METASTATIC COLORECTAL-CANCER; DELAYED ENDOCRINE TREATMENT; TERM-FOLLOW-UP; RADICAL PROSTATECTOMY; ANDROGEN-DEPRIVATION; RADIATION-THERAPY; LOCAL TREATMENT; HEPATIC RESECTION; PRIMARY TUMOR;
D O I
10.1016/j.semradonc.2016.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Historically, stage IV prostate cancer was considered incurable. Although node-positive and oligometastatic prostate cancers are both classified as stage IV, these likely represent distinct clinical groups, and some patients may be curable with aggressive multimodality treatments. There is a lack of randomized evidence, but retrospective studies suggest that radical prostatectomy or radiotherapy may improve survival in these patients. This is an area of great current research interest and prospective randomized trials are needed to help define the optimal treatments for these patients. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 50 条
  • [1] Role of radiotherapy in the management of node-positive prostate cancer
    Supiot, S.
    Dore, M.
    Rio, E.
    Cellier, P.
    Mesguez-Nebout, N.
    Goineau, A.
    CANCER RADIOTHERAPIE, 2016, 20 (6-7): : 442 - 444
  • [2] Radiotherapy in node-positive prostate cancer
    Bottke, D.
    Bartkowiak, D.
    Bolenz, C.
    Wiegel, T.
    UROLOGE, 2016, 55 (03): : 345 - 349
  • [3] Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy
    Hayden, Christopher
    Rahman, Syed
    Lokeshwar, Soum
    Choksi, Ankur
    Kim, Isaac Y. Y.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (07) : 729 - 734
  • [4] Narrative review of management strategies and outcomes in node-positive prostate cancer
    D'Rummo, Kevin A.
    Chen, Ronald C.
    Shen, Xinglei
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (07) : 3176 - 3187
  • [5] Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy
    Christopher Hayden
    Syed Rahman
    Soum Lokeshwar
    Ankur Choksi
    Isaac Y. Kim
    Current Oncology Reports, 2023, 25 : 729 - 734
  • [6] The Role of Radiotherapy in Node-Positive Prostate Cancer
    Baker, Brock R.
    Mohiudin, Jahan J.
    Chen, Ronald C.
    ONCOLOGY-NEW YORK, 2015, 29 (02): : 108 - 116
  • [7] Surgical Management of Node-positive Prostate Cancer: Perspectives from Breast Oncology
    Kennecke, Hagen F.
    Keyes, Mira
    EUROPEAN UROLOGY, 2014, 66 (02) : 202 - 203
  • [8] Management of Lymph Node-Positive Prostate Cancer: The Role of Surgery and Radiation Therapy
    Mitin, Timur
    Blute, Michael
    Lee, Richard
    Efstathiou, Jason
    ONCOLOGY-NEW YORK, 2013, 27 (07): : 647 - 655
  • [9] Management of the neck in node-positive tonsillar cancer
    Marklund, Linda
    Lundberg, Bertil
    Hammarstedt-Nordenvall, Lalle
    ACTA OTO-LARYNGOLOGICA, 2014, 134 (10) : 1094 - 1100
  • [10] Prognostic factors in lymph node-positive prostate cancer
    Hofer, Matthias D.
    Kuefer, Rainer
    Huang, Wei
    Li, Haojie
    Bismar, Tarek A.
    Perner, Sven
    Hautmann, Richard E.
    Sanda, Martin G.
    Gschwend, Juergen E.
    Rubin, Mark A.
    UROLOGY, 2006, 67 (05) : 1016 - 1021